scispace - formally typeset
Open AccessJournal ArticleDOI

Butyrate: A Double-Edged Sword for Health?

TLDR
The present knowledge on the properties of butyrate, especially its potential effects and mechanisms involved in intestinal health and obesity, are summarized.
About
This article is published in Advances in Nutrition.The article was published on 2018-01-01 and is currently open access. It has received 542 citations till now. The article focuses on the topics: Butyrate & Gut–brain axis.

read more

Citations
More filters
Journal ArticleDOI

Branched Chain Amino Acids: Beyond Nutrition Metabolism

TL;DR: Current evidence supports BCAAs and their derivatives as the potential biomarkers of diseases such as insulin resistance, type 2 diabetes mellitus, cancer, and cardiovascular diseases (CVDs), and optimizing dietary BCAA levels should have a positive effect on the parameters associated with health and diseases.
Journal ArticleDOI

Impact of Diet-Modulated Butyrate Production on Intestinal Barrier Function and Inflammation.

TL;DR: The effect of butyrate seems generally to be more consistent and positive oninflammatory markers related to the gut than on inflammatory markers in the peripheral tissue, and this discrepancy may be explained by differences inbutyrate concentrations in the gut compared with the much lower concentration at more remote sites.
Journal ArticleDOI

Postbiotics and Their Potential Applications in Early Life Nutrition and Beyond.

TL;DR: A working definition and review currently known postbiotic compounds, their proposed mechanisms, clinical evidence and potential applications are proposed.
Journal ArticleDOI

Nondigestible carbohydrates, butyrate, and butyrate-producing bacteria

TL;DR: In this review, several representative NDCs are introduced, and their chemical components, structures, and physiological functions, including promotion of the proliferation of butyrate-producing bacteria and enhancement ofbutyrate production are discussed.
Journal ArticleDOI

Clostridium species as probiotics: potentials and challenges.

TL;DR: This review summarized the researches involved in benefits and potential risks of Clostridium species to the authors' health, in order to develop Clostridgeium species as novel probiotics for human health and animal production.
References
More filters
Journal ArticleDOI

An obesity-associated gut microbiome with increased capacity for energy harvest

TL;DR: It is demonstrated through metagenomic and biochemical analyses that changes in the relative abundance of the Bacteroidetes and Firmicutes affect the metabolic potential of the mouse gut microbiota and indicates that the obese microbiome has an increased capacity to harvest energy from the diet.
Journal ArticleDOI

Lysine Acetylation Targets Protein Complexes and Co-Regulates Major Cellular Functions

TL;DR: A proteomic-scale analysis of protein acetylation suggests that it is an important biological regulatory mechanism and the regulatory scope of lysine acetylations is broad and comparable with that of other major posttranslational modifications.
Journal ArticleDOI

The Microbial Metabolites, Short-Chain Fatty Acids, Regulate Colonic Treg Cell Homeostasis

TL;DR: This study determined that short-chain fatty acids, gut microbiota–derived bacterial fermentation products, regulate the size and function of the colonic Treg pool and protect against colitis in a Ffar2-dependent manner in mice, revealing that a class of abundant microbial metabolites underlies adaptive immune microbiota coadaptation and promotes colonic homeostasis and health.
Journal ArticleDOI

From Dietary Fiber to Host Physiology: Short-Chain Fatty Acids as Key Bacterial Metabolites

TL;DR: Data is reviewed supporting the diverse functional roles carried out by a major class of bacterial metabolites, the short-chain fatty acids (SCFAs), which affect various physiological processes and may contribute to health and disease.
Journal ArticleDOI

Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour

TL;DR: The emerging concept of a microbiota–gut–brain axis suggests that modulation of the gut microbiota may be a tractable strategy for developing novel therapeutics for complex CNS disorders.
Related Papers (5)